Short-Term Regulation of Lipocalin-2 but not RBP-4 During Oral Lipid Tolerance Test and Oral Glucose Tolerance Test

Abstract

The postprandial regulation of lipocalin-2 and retinol binding protein-4 (RBP-4) by oral uptake of lipids and carbohydrates in healthy individuals has not yet been investigated. The regulation of lipocalin-2 and RBP-4 in 2 large cohorts of healthy volunteers during oral lipid tolerance test (OLTT; n=100) and oral glucose tolerance test (OGTT; n=100) was analyzed. One hundred healthy volunteers underwent OLTT and OGTT in an outpatient setting. Venous blood was drawn after 0, 2, 4, and 6 h in OLTT and after 0, 1, and 2 h in OGTT. In order to dissect carbohydrate-induced from lipid-induced effects, a novel OLTT solution completely free of carbohydrates and protein was applied. Subjects were characterized by anthropometric and laboratory parameters. Serum concentrations of lipocalin-2 and RBP-4 were measured by enzyme-linked immunosorbent assay (ELISA). Whereas RBP-4 levels remained unchanged during OGTT, lipocalin-2 concentrations significantly decreased during OGTT. During OLTT, RBP-4 levels were not influenced, whereas lipocalin-2 levels decreased significantly and stepwise. Fasting concentrations of RBP-4 were negatively correlated with BMI and waist-hip ratio, whereas lipocalin-2 levels were positively associated with BMI and waist-hip ratio. Female users of hormonal contraception had higher RBP-4 levels than females not on contraceptives. There is no significant short-term regulation of RBP-4 by orally ingested lipids or carbohydrates. Lipocalin-2 is downregulated after lipid and carbohydrate ingestion and this kind of regulation was not predicted by age, sex, triglycerides, glucose, or insulin levels.

Key words

lipocalin-2 - RBP-4 - glucose tolerance test - lipid tolerance test

• References

• 1 Koerner A, Kratzsch J, Kiess W. Adipocytokines: leptin – the classical, resistin – the controversial, adiponectin – the promising, and more to come. Best Pract Res Clin Endocrinol Metab 2005; 19: 525-546
• 2 Flehmig G, Scholz M, Kloting N, Fasshauer M, Tonjes A, Stumvoll M, Youn BS, Bluher M. Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation. PloS one 2014; 9: e99785
• 3 Bose KS, Gupta SK, Singh S. Is serum retinol binding protein-4: A predictor for diabetes in genetically high risk population?. J Res Med Sci 2012; 17: 1015-1019
• 4 Kotnik P, Fischer-Posovszky P, Wabitsch M. RBP4: a controversial adipokine. Eur J Endocrinol 2011; 165: 703-711
• 5 Christou GA, Tselepis AD, Kiortsis DN. The metabolic role of retinol binding protein 4: an update. Horm Metab Res 2012; 44: 6-14
• 6 Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Schleicher E, Fritsche A, Haring HU. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care 2007; 30: 1173-1178
• 7 Mohapatra J, Sharma M, Singh S, Pandya G, Chatterjee A, Balaraman R, Patel PR, Jain MR. Involvement of adipokines in rimonabant-mediated insulin sensitivity in ob/ob mice. J Pharm Pharmacol 2009; 61: 1493-1498
• 8 Rodvold JJ, Mahadevan NR, Zanetti M. Lipocalin 2 in cancer: when good immunity goes bad. Cancer letters 2012; 316: 132-138
• 9 Wu G, Li H, Zhou M, Fang Q, Bao Y, Xu A, Jia W. Mechanism and clinical evidence of lipocalin-2 and adipocyte fatty acid-binding protein linking obesity and atherosclerosis. Diabetes Metab Res Rev 2014; 30: 447-456
• 10 Wang Y. Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2. British journal of pharmacology 2012; 165: 603-621
• 11 Jang Y, Lee JH, Wang Y, Sweeney G. Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome. Clin Exp Pharmacol Physiol 2012; 39: 194-199
• 12 Guo H, Jin D, Chen X. Lipocalin 2 is a regulator of macrophage polarization and NF-kappaB/STAT3 pathway activation. Mol Endocrinol 2014; 28: 1616-1628
• 13 Zhang Y, Guo H, Deis JA, Mashek MG, Zhao M, Ariyakumar D, Armien AG, Bernlohr DA, Mashek DG, Chen X. Lipocalin 2 Regulates Brown Fat Activation via a Nonadrenergic Activation Mechanism. J Biol Chem 2014; 289: 22063-22077
• 14 Bala M, Martin J, Kopp A, Hanses F, Buechler C, Schaffler A. In vivo suppression of visfatin by oral glucose uptake: evidence for a novel incretin-like effect by glucagon-like peptide-1 (GLP-1). J Clin Endocrinol Metab 2011; 96: 2493-2501
• 15 Karrasch T, Leszczak S, Bala M, Ober I, Martin J, Schmid A, Kopp A, Schaffler A. Short-term regulation of Visfatin release in vivo by oral lipid ingestion and in vitro by fatty acid stimulation. Exp Clin Endocrinol Diabetes 2014; 122: 126-134
• 16 Hoggard N, Agouni A, Mody N, Delibegovic M. Serum levels of RBP4 and adipose tissue levels of PTP1B are increased in obese men resident in northeast Scotland without associated changes in ER stress response genes. Int J Gen Med 2012; 5: 403-411
• 17 El-Mesallamy HO, Hamdy NM, Sallam AA. Effect of obesity and glycemic control on serum lipocalins and insulin-like growth factor axis in type 2 diabetic patients. Acta Diabetol 2013; 50: 679-685
• 18 Choi SH, Lee YJ, Park YJ, Kim KW, Lee EJ, Lim S, Park do J, Kim SE, Park KS, Jang HC, Cho BY. Retinol binding protein-4 elevation is associated with serum thyroid-stimulating hormone level independently of obesity in elderly subjects with normal glucose tolerance. J Clin Endocrinol Metab 2008; 93: 2313-2318
• 19 Wallenius V, Elias E, Bergstrom GM, Zetterberg H, Behre CJ. The lipocalins retinol-binding protein-4, lipocalin-2 and lipocalin-type prostaglandin D2-synthase correlate with markers of inflammatory activity, alcohol intake and blood lipids, but not with insulin sensitivity in metabolically healthy 58-year-old Swedish men. Exp Clin Endocrinol Diabetes 2011; 119: 75-80
• 20 Derosa G, Maffioli P, D’Angelo A, Fogari E, Bianchi L, Cicero AF. Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study. J Diabetes Complicat 2011; 25: 258-266
• 21 Li L, Wang C, Bao Y, Wu H, Lu J, Xiang K, Jia W. Serum retinol-binding protein 4 is associated with insulin secretion in Chinese people with normal glucose tolerance. J Diabetes 2009; 1: 125-130
• 22 Ueland T, Dalsoren T, Voldner N, Godang K, Henriksen T, Bollerslev J. Retinol-binding protein-4 is not strongly associated with insulin sensitivity in normal pregnancies. Eur J Endocrinol 2008; 159: 49-54
• 23 Terra X, Auguet T, Aguera Z, Quesada IM, Orellana-Gavalda JM, Aguilar C, Jimenez-Murcia S, Berlanga A, Guiu-Jurado E, Menchon JM, Fernandez-Aranda F, Richart C. Adipocytokine levels in women with anorexia nervosa. Relationship with weight restoration and disease duration. Int J Eating Disorders 2013; 46: 855-861